The DOI matches its Crossref record; 196 of the 196 references it cites were found in a registry or an index.
Pharmacology and Therapeutic Potential of Sigma1 Receptor Ligands
Open accessAbstract
Sigma (sigma) receptors, initially described as a subtype of opioid receptors, are now considered unique receptors. Pharmacological studies have distinguished two types of sigma receptors, termed sigma(1) and sigma(2). Of these two subtypes, the sigma(1) receptor has been cloned in humans and rodents, and its amino acid sequence shows no homology with other mammalian proteins. Several psychoactive drugs show high to moderate affinity for sigma(1) receptors, including the antipsychotic haloperidol, the antidepressant drugs fluvoxamine and sertraline, and the psychostimulants cocaine and methamphetamine; in addition, the anticonvulsant drug phenytoin allosterically modulates sigma(1) receptors. Certain neurosteroids are known to interact with sigma(1) receptors, and have been proposed to be their endogenous ligands. These receptors are located in the plasma membrane and in subcellular membranes, particularly in the endoplasmic reticulum, where they play a modulatory role in intracellular Ca(2+) signaling. Sigma(1) receptors also play a modulatory role in the activity of some ion channels and in several neurotransmitter systems, mainly in glutamatergic neurotransmission. In accordance with their widespread modulatory role, sigma(1) receptor ligands have been proposed to be useful in several therapeutic fields such as amnesic and cognitive deficits, depression and anxiety, schizophrenia, analgesia, and against some effects of drugs of abuse (such as cocaine and methamphetamine). In this review we provide an overview of the present knowledge of sigma(1) receptors, focussing on sigma(1) ligand neuropharmacology and the role of sigma(1) receptors in behavioral animal studies, which have contributed greatly to the potential therapeutic applications of sigma(1) ligands.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., & Monteggia, L. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00653-0 · Cited by 3,217
Martin, W. R., Eades, C. G., Thompson, J. A., Huppler, R. E., & Gilbert, P. E. (1976) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30536-7 · Cited by 2,992
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
Green, A. R., Mechan, A. O., Elliott, J. M., O’Shea, E., & Colado, M. I. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.3 · Cited by 1,272
Glutamate receptor function in learning and memory
Riedel, G. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00272-3 · Cited by 962
Purification, molecular cloning, and expression of the mammalian sigma1-binding site.
Hanner, M., Moebius, F. F., Flandorfer, A., Knaus, H. G., Striessnig, J., Kempner, E., & Glossmann, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.8072 · Cited by 911
Bartus, R. T. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7397 · Cited by 829
Sigma receptors: biology and function.
Walker, J. M., Bowen, W. D., Walker, F. O., Matsumoto, R. R., De Costa, B., & Rice, K. C. (1990) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00047-x · Cited by 825
Hormesis: The Dose-Response Revolution
Calabrese, E. J., & Baldwin, L. A. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140223 · Cited by 795
A proposal for the classification of sigma binding sites
Quirion, R., Bowen, W. D., Itzhak, Y., Junien, J. L., Musacchio, J., Rothman, R. B., Tsung-Ping, S., Tam, S. W., & Taylor, D. P. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90030-a · Cited by 755
New Insights into the Mechanism of Action of Amphetamines
Fleckenstein, A. E., Volz, T. J., Riddle, E. L., Gibb, J. W., & Hanson, G. R. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105140 · Cited by 731
NEUROSTEROIDS: A NOVEL FUNCTION OF THE BRAIN
Baulieu, E. E. (1998) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(98)00071-7 · Cited by 622
Steroid Binding at σ Receptors Suggests a Link Between Endocrine, Nervous, and Immune Systems
Su, T.-P., London, E. D., & Jaffe, J. H. (1988) · Science · doi:10.1126/science.2832949 · Cited by 546
Monoamine transporters and psychostimulant drugs
Rothman, R. B., & Baumann, M. H. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.054 · Cited by 502
The chemical biology of clinically tolerated NMDA receptor antagonists
Chen, H. V., & Lipton, S. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03991.x · Cited by 474
Cloning and Functional Expression of the Human Type 1 Sigma Receptor (hSigmaR1)
Kekuda, R., Prasad, P. D., Fei, Y.-J., Leibach, F. H., & Ganapathy, V. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1842 · Cited by 418
The Sigma Receptor as a Ligand-Regulated Auxiliary Potassium Channel Subunit
Aydar, E., Palmer, C. P., Klyachko, V. A., & Jackson, M. B. (2002) · Neuron · doi:10.1016/s0896-6273(02)00677-3 · Cited by 398
Hellewell, S. B., Bruce, A., Feinstein, G., Orringer, J., Williams, W., & Bowen, W. D. (1994) · European Journal of Pharmacology: Molecular Pharmacology · doi:10.1016/0922-4106(94)90115-5 · Cited by 390
Immunocytochemical localization of the sigma1 receptor in the adult rat central nervous system
Alonso, G., Phan, V.-L., Guillemain, I., Saunier, M., Legrand, A., Anoal, M., & Maurice, T. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00014-2 · Cited by 366
Hellewell, S. B., & Bowen, W. D. (1990) · Brain Research · doi:10.1016/0006-8993(90)91143-5 · Cited by 341
The role of prenatal stress in the etiology of developmental behavioural disorders
Kofman, O. (2002) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(02)00015-5 · Cited by 332
Regulating ankyrin dynamics: Roles of sigma-1 receptors
Hayashi, T., & Su, T.-P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.491 · Cited by 329
Todorovic, S. M., & Lingle, C. J. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.79.1.240 · Cited by 317
Bergeron, R., de Montigny, C., & Debonnel, G. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-03-01193.1996 · Cited by 299
HAYASHI, T., Maurice, T., & Su, T. (2000) · PubMed · Cited by 296
??-1 Receptor Ligands: Potential in the Treatment of Neuropsychiatric Disorders
Hayashi, T., & Su, T.-P. (2004) · CNS Drugs · doi:10.2165/00023210-200418050-00001 · Cited by 294
Maurice, T., Su, T.-P., & Privat, A. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00405-3 · Cited by 291
Cloning and Functional Characterization of a σ Receptor from Rat Brain
Seth, P., Fei, Y., Li, H. W., Huang, W., Leibach, F. H., & Ganapathy, V. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70030922.x · Cited by 290
Meunier, J., Ieni, J., & Maurice, T. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706927 · Cited by 288
Matsumoto, R. R., Bowen, W. D., Tom, M. A., Vo, V. N., Truong, D. D., & De Costa, B. R. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00208-3 · Cited by 268
Interactions of selective serotonin reuptake inhibitors with subtypes of σ receptors in rat brain
Narita, N., Hashimoto, K., Tomitaka, S.-I., & Minabe, Y. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00254-3 · Cited by 254 · cited 4×
“Fluvoxamine 1 [149] +++ [149] Agonist [61] Selective 5-HT reuptake inhibitor [149, 61]”
BackgroundInfluentialRole of norepinephrine in depression.
Delgado, P. L., & Moreno, F. A. (2000) · PubMed · Cited by 251
Neurocognitive impairment across the lifespan in schizophrenia: an update
KURTZ, M. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2004.07.005 · Cited by 243
Sigma receptors: recent advances and new clinical potentials
Bowen, W. D. (2000) · Pharmaceutica Acta Helvetiae · doi:10.1016/s0031-6865(99)00034-5 · Cited by 241
Sigma receptors: biology and therapeutic potential
Guitart, X., Codony, X., & Monroy, X. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1920-9 · Cited by 234
Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses
Law, A. J., & Deakin, J. F. W. (2001) · Neuroreport · doi:10.1097/00001756-200109170-00043 · Cited by 227
Maurice, T., Urani, A., Phan, V.-L., & Romieu, P. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00112-6 · Cited by 223
Neuroprotective and anti-amnesic potentials of sigma (σ) receptor ligands
Maurice, T., & Lockhart, B. P. (1997) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(96)00160-1 · Cited by 211
Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia
Castner, S., Goldman-Rakic, P., & Williams, G. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1710-9 · Cited by 208
Cloning and Structural Analysis of the cDNA and the Gene Encoding the Murine Type 1 Sigma Receptor
Seth, P., Leibach, F. H., & Ganapathy, V. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7840 · Cited by 201
South, S. M., Kohno, T., Kaspar, B. K., Hegarty, D., Vissel, B., Drake, C. T., Ohata, M., Jenab, S., Sailer, A. W., Malkmus, S., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-12-05031.2003 · Cited by 188
Martina, M., Turcotte, M. B., Halman, S., & Bergeron, R. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2006.116178 · Cited by 187
Urani, A., Roman, F. J., Phan, V. L., Su, T., & Maurice, T. (2001) · PubMed · Cited by 181
Maurice, T., Phan, V.-L., Urani, A., Kamei, H., Noda, Y., & Nabeshima, T. (1999) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.81.125 · Cited by 178
Morin-Surun, M. P., Collin, T., Denavit-Saubié, M., Baulieu, E.-E., & Monnet, F. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.8196 · Cited by 170
Generation and phenotypic analysis of sigma receptor type I (σ1) knockout mice
Langa, F., Codony, X., Tovar, V., Lavado, A., Giménez, E., Cozar, P., Cantero, M., Dordal, A., Hernández, E., Pérez, R., et al. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02950.x · Cited by 167
Monnet, F. P., & Maurice, T. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.cr0050032 · Cited by 166
Sigma1 (σ1) receptor antagonists represent a new strategy against cocaine addiction and toxicity
Maurice, T., Martin‐Fardon, R., Romieu, P., & Matsumoto, R. R. (2002) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(02)00017-9 · Cited by 165
Maurice, T., Gregoire, C. J., & Espallergues, J. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.07.009 · Cited by 161
σ Receptors: potential medications development target for anti-cocaine agents
Matsumoto, R. R., Liu, Y., Lerner, M., Howard, E. W., & Brackett, D. J. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01723-0 · Cited by 160
Hashimoto, K., Fujita, Y., Shimizu, E., & Iyo, M. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.07.002 · Cited by 159
The antidepressant mechanism of Hypericum perforatum
Mennini, T., & Gobbi, M. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.04.005 · Cited by 159
Selective antagonism of opioid analgesia by a sigma system.
Chien, C., & Pasternak, G. W. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24045-9 · Cited by 156
Bowen, W. D., Moses, E. L., Tolentino, P. J., & Walker, J. M. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90260-d · Cited by 154
The Role of Sigma Receptors in Depression
Bermack, J. E., & Debonnel, G. (2005) · Journal of Pharmacological Sciences · doi:10.1254/jphs.crj04005x · Cited by 153
The Sigma Receptor: Evolution of the Concept in Neuropsychopharmacology
HAYASHI, T., & Su, T. (2005) · Current Neuropharmacology · doi:10.2174/157015905774322516 · Cited by 152
Nudmamud‐Thanoi, S., & Reynolds, G. P. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.09.035 · Cited by 150
Hashimoto, K., Fujita, Y., & Iyo, M. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301047 · Cited by 148
Nguyen, E. C., McCracken, K. A., Liu, Y., Pouw, B., & Matsumoto, R. R. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.04.016 · Cited by 146
Evidence for a multi-site model of the rat brain σ receptor
Bowen, W. D., Hellewell, S. B., & McGarry, K. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90200-8 · Cited by 143
Takebayashi, M., Hayashi, T., & Su, T.-P. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.041970 · Cited by 142
Ishikawa, M., Ishiwata, K., Ishii, K., Kimura, Y., Sakata, M., Naganawa, M., Oda, K., Miyatake, R., Fujisaki, M., Shimizu, E., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.04.001 · Cited by 141
Formalin-induced pain is reduced in σ1 receptor knockout mice
Cendán, C. M., Pujalte, J. M., Portillo-Salido, E. F., Montoliu, L., & Baeyens, J. M. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.01.036 · Cited by 141
Neurosteroids Enhance Spontaneous Glutamate Release in Hippocampal Neurons
Meyer, D. A., Carta, M., Partridge, L. D., Covey, D. F., & Valenzuela, C. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202592200 · Cited by 137
ς1 Receptor Modulation of Opioid Analgesia in the Mouse
Mei, J., & Pasternak, G. W. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.1070 · Cited by 132
Kim, Y. K. (2003) · Journal of the Korean Medical Association · doi:10.5124/jkma.2003.46.9.783 · Cited by 129
Yagasaki, Y., Numakawa, T., Kumamaru, E., Hayashi, T., Su, T.-P., & Kunugi, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508157200 · Cited by 122 · cited 2×
“Sigma1 receptor activation by agonists induces the dissociation of the 1 receptor-ANK220 complex from the InsP3 receptors [60], potentiating the calcium efflux induced by receptors that activates the PLC system (such as receptors for bradykinin and brain-derived neurotrophic factor) [59, 60, 70, 162, 222].”
BackgroundRomieu, P. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00391-8 · Cited by 121
Neuroprotective effects of sigma-1 receptor agonists against beta-amyloid-induced toxicity
Marrazzo, A., Caraci, F., Salinaro, E. T., Su, T., Copani, A., & Ronsisvalle, G. (2005) · Neuroreport · doi:10.1097/00001756-200508010-00018 · Cited by 120
Katnik, C. P., Guerrero, W. R., Pennypacker, K. R., Herrera, Y., & Cuevas, J. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.107557 · Cited by 115
Lupardus, P. J., Wilke, R. A., Aydar, E., Palmer, C. P., Chen, Y., Ruoho, A. E., & Jackson, M. B. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00527.x · Cited by 113
Sigma antagonists potentiate opioid analgesia in rats
Chien, C., & Pasternak, G. W. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11504-p · Cited by 112
Kim, H., Kwon, Y., Roh, D., Yoon, S., Han, H. J., Kim, K.-W., Beitz, A. J., & Lee, J. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706764 · Cited by 111
Moebius, F. F., Reiter, R. J., Hanner, M., & Glossmann, H. H. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701079 · Cited by 111
Involvement of the σ1 receptor in the cocaine-induced conditioned place preference
Romieu, P., Martin‐Fardon, R., & Maurice, T. (2000) · Neuroreport · doi:10.1097/00001756-200009110-00011 · Cited by 108
Involvement of the sigma1 receptor in the modulation of dopaminergic transmission by amantadine
Peeters, M., Romieu, P., Maurice, T., Su, T., Maloteaux, J., & Hermans, E. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03297.x · Cited by 107
Matsumoto, R. R., McCracken, K. A., Pouw, B., Zhang, Y., & Bowen, W. D. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00056-4 · Cited by 106
σ Receptor antagonists block the development of sensitization to cocaine
Ujike, H., Kuroda, S., & Otsuki, S. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00693-1 · Cited by 104
Repeated Cocaine Administration Induces Gene Expression Changes through the Dopamine D1 Receptors
Zhang, D., Zhang, L., Tang, Y., Zhang, Q., Lou, D., Sharp, F. R., Zhang, J., & Xu, M. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300680 · Cited by 102
Kitaichi, K., Chabot, J., Moebius, F. F., Flandorfer, A., Glossmann, H. H., & Quirion, R. (2000) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(00)00106-x · Cited by 102
Hayashi, T., & Su, T. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.009 · Cited by 100
Maurice, T., Roman, F. J., & Privat, A. (1996) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19961215)46:6<734::aid-jnr10>3.0.co;2-u · Cited by 100
Sigma‐1 receptor as regulator of neuronal intracellular Ca2+: clinical and therapeutic relevance
Monnet, F. P. (2005) · Biology of the Cell · doi:10.1042/bc20040149 · Cited by 100
Kibaly, C., Meyer, L., Patte‐Mensah, C., & Mensah‐Nyagan, A. G. (2007) · The FASEB Journal · doi:10.1096/fj.07-8930com · Cited by 95
Kato, K., Hayako, H., Ishihara, Y., Marui, S., Iwane, M., & Miyamoto, M. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00943-4 · Cited by 95
Ukai, M., Maeda, H., Nanya, Y., Kameyama, T., & Matsuno, K. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00093-8 · Cited by 94
Antinociceptive effects of haloperidol and its metabolites in the formalin test in mice
Cendán, C. M., Pujalte, J. M., Portillo-Salido, E. F., & Baeyens, J. M. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0127-z · Cited by 91
A Presynaptic Action of the Neurosteroid Pregnenolone Sulfate on GABAergic Synaptic Transmission
Mtchedlishvili, Z., & Kapur, J. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.4.857 · Cited by 91
Modulation of serotonergic neurotransmission by short‐ and long‐term treatments with sigma ligands
Bermack, J. E., & Debonnel, G. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704294 · Cited by 89
Role of serotonin in cocaine effects in mice with reduced dopamine transporter function
Mateo, Y., Budygin, E. A., John, C. E., & Jones, S. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0207805101 · Cited by 88
Romieu, P., Meunier, J., Garcia, D., Zozime, N., Martin-Fardon, R., Bowen, W. D., & Maurice, T. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1814-x · Cited by 86
Seth, P., Ganapathy, M. E., Conway, S. J., Bridges, C. D., Smith, S. B., Casellas, P., & Ganapathy, V. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(01)00117-3 · Cited by 86
Identification of Regions of the σ-1 Receptor Ligand Binding Site Using a Novel Photoprobe
Pal, A., Hajipour, A. R., Fontanilla, D., Ramachandran, S., Chu, U. B., Mavlyutov, T. A., & Ruoho, A. E. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.038307 · Cited by 86
Zhang, H., & Cuevas, J. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084152 · Cited by 86
Takebayashi, M., Hayashi, T., & Su, T. (2004) · Synapse · doi:10.1002/syn.20041 · Cited by 84
Walker, J. M., Bowen, W. D., Patrick, S. L., Williams, W. E., Mascarella, S. W., Bai, X., & Carroll, F. I. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90684-a · Cited by 83
Enhanced κ-opioid receptor-mediated analgesia by antisense targeting the σ1 receptor
King, M., Pan, Y., Mei, J., Chang, A., Xu, J., & Pasternak, G. W. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01064-9 · Cited by 82
Gekker, G., Hu, S., Sheng, W. S., Rock, R. B., Lokensgard, J. R., & Peterson, P. K. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2005.12.005 · Cited by 82
Maurice, T., Meunier, J., Feng, B., Ieni, J. R., & Monaghan, D. T. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.097394 · Cited by 81
Roth, M. D., Whittaker, K., Choi, R., Tashkin, D. P., & Baldwin, G. C. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0405219 · Cited by 80
Regulating ankyrin dynamics: Roles of sigma-1 receptors
Hayashi, T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.021413698 · Cited by 80
Stefański, R., Justinová, Z., Hayashi, T., Takebayashi, M., Goldberg, S. R., & Su, T. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1779-9 · Cited by 78
Martin‐Fardon, R., Maurice, T., Aujla, H., Bowen, W. D., & Weiss, F. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301323 · Cited by 74
Dong, L.-Y., Cheng, Z., Fu, Y., Wang, Z.-M., Zhu, Y., Sun, J., Dong, Y. W., & Zheng, P. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.10.015 · Cited by 74
Monnet, F. P., Morin-Surun, M. P., Leger, J., & Combettes, L. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.053447 · Cited by 74
Itzhak, Y., Stein, I., Zhang, S.-H., Kassim, C. O., & Cristante, D. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24697-3 · Cited by 74
Sigma (σ) antagonist BMY 14802 prevents methamphetamine-induced sensitization
Ujike, H., Kanzaki, A., Okumura, K., Akiyama, K., & Otsuki, S. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90466-3 · Cited by 73
Characterization of the Cocaine Binding Site on the Sigma-1 Receptor
Chen, Y., Hajipour, A. R., Sievert, M. K., Arbabian, M. A., & Ruoho, A. E. (2007) · Biochemistry · doi:10.1021/bi061727o · Cited by 73
Expression, Subcellular Localization, and Regulation of Sigma Receptor in Retinal Müller Cells
Jiang, G., Mysona, B. A., Dun, Y., Gnana‐Prakasam, J. P., Pabla, N., Li, W., Dong, Z., Ganapathy, V., & Smith, S. B. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0608 · Cited by 72
Cobos, E. J., Baeyens, J. M., & Pozo, E. D. (2005) · Synapse · doi:10.1002/syn.20103 · Cited by 71
Self-citationMethamphetamine-induced behavioral sensitization and its implications for relapse of schizophrenia
Akiyama, K., Kanzaki, A., Tsuchida, K., & Ujike, H. (1994) · Schizophrenia Research · doi:10.1016/0920-9964(94)90035-3 · Cited by 70
Monnet, F. P., Debonnel, G., Bergeron, R., Gronier, B., & de Montigny, C. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb13134.x · Cited by 70
Shin, E., Nah, S.-Y., Kim, W., Ko, K. H., Jhoo, W., Lim, Y. K., Cha, J. Y., Chen, C., & Kim, H. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705998 · Cited by 69
Clinical Trials with Sigma Ligands
Volz, H., & Stoll, K.-D. (2004) · Pharmacopsychiatry · doi:10.1055/s-2004-832680 · Cited by 69
John, C. S., Vilner, B. J., & Bowen, W. D. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00038a002 · Cited by 69
Metabotropic neurosteroid/sigma-receptor involved in stimulation of nociceptor endings of mice.
Ueda, H., Inoue, M., Yoshida, A., Mizuno, K., Yamamoto, H., Maruo, J., Matsuno, K., & Mita, S. (2001) · PubMed · Cited by 66
Rush, A. M., & Elliott, J. R. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00258-9 · Cited by 65
Involvement of σ1 receptors in methamphetamine-induced behavioral sensitization in rats
Takahashi, S., Miwa, T., & Horikomi, K. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01258-1 · Cited by 65
Involvement of the sigma1 receptor in the motivational effects of ethanol in mice
Maurice, T., Casalino, M., Lacroix, M., & Romieu, P. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00002-9 · Cited by 65
Regional distribution of cocaine in postmortem brain of chronic human cocaine users.
Kalasinsky, K., Bosy, T., Schmunk, G., Ang, L., Adams, V, Gore, S., Smialek, J., Furukawa, Y., Guttman, M., & Kish, S. (2000) · Journal of Forensic Sciences · doi:10.1520/jfs14828j · Cited by 63
BMY 14802, a Sigma Receptor Ligand for the Treatment of Schizophrenia
Gewirtz, G. R., Gorman, J. M., Volavka, J., Macaluso, J., Gribkoff, G., Taylor, D. P., & Borison, R. L. (1994) · Neuropsychopharmacology · doi:10.1038/npp.1994.5 · Cited by 63
Wilke, R. A., Lupardus, P. J., Grandy, D. K., Rubinstein, M., Low, M. J., & Jackson, M. B. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.00391.x · Cited by 63
Dussossoy, D., Carayon, P., Belugou, S., Feraut, D., Bord, A., Goubet, C., Roque, C., Vidal, H., Combes, T., Loison, G., et al. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00500.x · Cited by 62 · cited 2×
“Immunohistochemical studies further confirmed the existence of 1 receptors in the endoplasmic reticulum not only in neurons [2], but also in many other cell types such as oligodendrocytes [160], lymphocytes [43], retinal cells [76] and certain cancer cells [62].”
BackgroundNeurosteroids Ameliorate Conditioned Fear Stress An Association with Sigma1 Receptors
Noda, Y. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00103-2 · Cited by 62
Witkin, J. M., Terry, P., Menkel, M., Hickey, P., Pontecorvo, M. J., Ferkany, J. W., & Katz, J. L. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38376-x · Cited by 62
[3H](+)-Pentazocine binding to rat brain σ1 receptors
Cagnotto, A., Bastone, A., & Mennini, T. (1994) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(94)90102-3 · Cited by 61
Matsumoto, R. R., Hewett, K. L., Pouw, B., Bowen, W. D., Husbands, S. M., Cao, J. J., & Newman, A. H. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00116-2 · Cited by 61
Chen, L., Dai, X., & Sokabe, M. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.10.015 · Cited by 59
Novel sigma (σ) receptor agonists produce antidepressant-like effects in mice
Wang, J., Mack, A. L., Coop, A., & Matsumoto, R. R. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.02.007 · Cited by 58
Palacios, G., Muro, A., Vela, J. M., Molina‐Holgado, E., Guitart, X., Ovalle, S., & Zamanillo, D. (2003) · Brain Research · doi:10.1016/s0006-8993(02)03892-1 · Cited by 58
Correlation between neuroleptic binding to σ1 and σ2 receptors and acute dystonic reactions
Matsumoto, R. R., & Pouw, B. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00430-1 · Cited by 58
Maurice, T., Phan, V., Urani, A., & Guillemain, I. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704355 · Cited by 57
Modulation of Brainstem Opiate Analgesia in the Rat by σ1 Receptors: A Microinjection Study
Mei, J., & Pasternak, G. W. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.121137 · Cited by 56
Hashimoto, K., & London, E. D. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)00763-w · Cited by 56
Steroid Binding at σ-"Opioid" Receptors
Schwarz, S., Pohl, P., & Zhou, G.-Z. (1989) · Science · doi:10.1126/science.2556797 · Cited by 54
Meunier, J., Gué, M., Récasens, M., & Maurice, T. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705835 · Cited by 51
Liu, Y., Chen, G., Lerner, M. R., Brackett, D. J., & Matsumoto, R. R. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084525 · Cited by 51
Soriani, O., Foll, F. L., Roman, F. J., Monnet, F. P., Vaudry, H., & Cazin, L. (1999) · PubMed · Cited by 50
Egashira, N., Harada, S., Okuno, R., Matsushita, M., Nishimura, R., Mishima, K., Iwasaki, K., Orito, K., & Fujiwara, M. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.02.019 · Cited by 49
Ligand-dependent localization and intracellular stability of sigma-1 receptors in CHO-K1 ce
Mavlyutov, T. A., & Ruoho, A. E. (2007) · Journal of Molecular Signaling · doi:10.1186/1750-2187-2-8 · Cited by 48
Antidepressant-like responses to the combined sigma and 5-HT1A receptor agonist OPC-14523
Tottori, K., Miwa, T., Uwahodo, Y., Yamada, S., Nakai, M., Oshiro, Y., Kikuchi, T., & Altar, C. A. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00147-2 · Cited by 46
Waterhouse, R. N., Chang, R. C., Atuehene, N., & Collier, T. L. (2007) · Synapse · doi:10.1002/syn.20369 · Cited by 46
Stone, J. M., Årstad, E., Erlandsson, K., et al. (2006) · Synapse · doi:10.1002/syn.20281 · Cited by 46
LePage, K. T., Ishmael, J. E., Low, C. M., Traynelis, S. F., & Murray, T. F. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.01.029 · Cited by 45
Hong, W. C., Nuwayhid, S. J., & Werling, L. L. (2004) · Synapse · doi:10.1002/syn.20069 · Cited by 45
Skuza, G., & Rogóż, Z. (2006) · PubMed · Cited by 45
Marrazzo, A., Parenti, C., Scavo, V., Ronsisvalle, S., Scoto, G. M., & Ronsisvalle, G. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.10.005 · Cited by 44
Urani, A., Romieu, P., Portales-Casamar, É., Roman, F. J., & Maurice, T. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1150-y · Cited by 44
Maurice, T., Phan, V., & Privat, A. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02152-7 · Cited by 44
Urani, A., Romieu, P., Roman, F. J., Yamada, K., Noda, Y., Kamei, H., Tran, H. M., Nagai, T., Nabeshima, T., & Maurice, T. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.12.018 · Cited by 43
Li, Z., Zhou, R., Cui, S., Xie, G., Cai, W., Sokabe, M., & Chen, L. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.06.007 · Cited by 43
Matsuno, K., Senda, T., Matsunaga, K., Mita, S., & KANETO, H. (1993) · Psychopharmacology · doi:10.1007/bf02247374 · Cited by 42
Takahashi, S., Sonehara, K., Takagi, K., Miwa, T., Horikomi, K., Mita, N., Nagase, H., Iizuka, K., & Sakai, K. (1999) · Psychopharmacology · doi:10.1007/s002130051061 · Cited by 41
Functional polymorphisms in the sigma1 receptor gene associated with alcoholism
Miyatake, R., Furukawa, A., Matsushita, S., Higuchi, S., & Suwaki, H. (2003) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.07.008 · Cited by 41
Cocaine modulates cytokine and enhances tumor growth through sigma receptors
Gardner, B. K., Zhu, L. X., Roth, M. D., Tashkin, D. P., Dubinett, S. M., & Sharma, S. P. (2003) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.10.020 · Cited by 41
Kamei, H., Kameyama, T., & Nabeshima, T. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00830-6 · Cited by 41
Interactions between 3,4-methylenedioxymethamphetamine and σ1 receptors
Brammer, M. K., Gilmore, D. L., & Matsumoto, R. R. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.09.038 · Cited by 40
NE‐100: A Novel Sigma Receptor Antagonist
Okuyama, S., & Nakazato, A. (1996) · CNS Drug Reviews · doi:10.1111/j.1527-3458.1996.tb00299.x · Cited by 40
Gué, M., Junien, J., Rio, C. D., & Bueno, L. P. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11154-3 · Cited by 40
Urani, A., Romieu, P., Roman, F. J., & Maurice, T. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00033-5 · Cited by 39
Pregnancy reduces brain sigma receptor function
Bergeron, R., de Montigny, C., & Debonnel, G. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702724 · Cited by 39
Involvement of sigma-1 receptor modulation in the antidepressant action of venlafaxine.
Dhir, A., & Kulkarni, S. K. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.04.055 · Cited by 39
Rogóż, Z., & Skuza, G. (2006) · PubMed · Cited by 38
A potential antidepressant activity of SA4503, a selective σ1 receptor agonist
Skuza, G., & Rogóż, Z. (2002) · Behavioural Pharmacology · doi:10.1097/00008877-200211000-00003 · Cited by 37
Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma?
Dépatie, L., & Lal, S. (2001) · PubMed · Cited by 37
Meunier, J., Ieni, J. R., & Maurice, T. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.101527 · Cited by 35
Meunier, J., & Maurice, T. (2004) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2004.07.003 · Cited by 35
Cormaci, G., Mori, T., Hayashi, T., & Su, T. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.108415 · Cited by 34
Wang, D., Noda, Y., Tsunekawa, H., Zhou, Y., Miyazaki, M., Senzaki, K., Nitta, A., & Nabeshima, T. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.124685 · Cited by 34
σ2-Receptor Ligand-Mediated Inhibition of Inwardly Rectifying K+ Channels in the Heart
Monassier, L., Manoury, B., Bellocq, C., WEISSENBURGER, J., Greney, H., Zimmermann, D., Ehrhardt, J. D., Jaillon, P., Baró, I., & Bousquet, P. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.122044 · Cited by 34
Soriani, O., Foll, F. L., Galas, L., Roman, F. J., Vaudry, H., & Cazin, L. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.1.e73 · Cited by 32
Novàkovâ, M., Bruderová, V., Sulová, Z., et al. (2007) · PubMed · Cited by 31
Cocaine enhances memory storage in mice
Introini-Collison, I. B., & McGaugh, J. L. (1989) · Psychopharmacology · doi:10.1007/bf00589905 · Cited by 30
Kamei, H., Noda, Y., Kameyama, T., & Nabeshima, T. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00851-5 · Cited by 30
Ocular Hypotensive Action of Topical Flunarizine in the Rabbit: Role of ς1 Recognition Sites
Campana, G., Bucolo, C., Murari, G., & Spampinato, S. M. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.040584 · Cited by 29
Takahashi, S., Horikomi, K., & Kato, T. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01254-7 · Cited by 28
Effect of sigma ligands on the cocaine-induced convulsions in mice.
Skuza, G. (2000) · PubMed · Cited by 28
Meunier, J., Demeilliers, B., Célérier, A., & Maurice, T. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.07.019 · Cited by 27
Anti‐amnesic effect of dimemorfan in mice
Wang, H., Chien, J., Chou, Y., Liao, J., & Chen, C. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705117 · Cited by 27
Phan, V., Miyamoto, Y., Nabeshima, T., & Maurice, T. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20390 · Cited by 26
Romieu, P., Lucas, M., & Maurice, T. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300885 · Cited by 25
Dehydroepiandrosterone Alleviates Copulatory Disorder Induced by Social Stress in Male Rats
Mizuno, T., YOTSUYANAGI, S., Nagasaka, Y., & Namiki, M. (2006) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2006.00272.x · Cited by 25
Sigma2 (σ2) receptors as a target for cocaine action in the rat striatum
Nuwayhid, S. J., & Werling, L. L. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.077 · Cited by 23
Chavez-Noriega, L. E., Marino, M. J., Schaffhauser, H., Campbell, U. C., & Conn, P. J. (2005) · Current Neuropharmacology · doi:10.2174/1570159052773369 · Cited by 22
Marrazzo, A., Prezzavento, O., Pappalardo, M. S., Bousquet, E., Iadanza, M., Pike, V. W., & Ronsisvalle, G. (2002) · Il Farmaco · doi:10.1016/s0014-827x(01)01170-3 · Cited by 22
Bucolo, C., Marrazzo, A., Ronsisvalle, S., Ronsisvalle, G., Cuzzocrea, S., Mazzon, E., Caputi, A. P., & Drago, F. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.02.026 · Cited by 21
A discriminant block among K+ channel types by phenytoin in neuroblastoma cells
Nobile, M., & Lagostena, L. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702035 · Cited by 20
Hiramatsu, M., & Hoshino, T. (2004) · Brain Research · doi:10.1016/j.brainres.2004.10.020 · Cited by 20
Silvers, J. M., Wallace, D. R., Harrod, S. B., Mactutus, C. F., & Booze, R. M. (2006) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2006.01.009 · Cited by 19
DeHaven‐Hudkins, D. L., Lanyon, L. F., Ford-Rice, F. Y., & Ator, M. A. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90395-6 · Cited by 18
Maruo, J., Yoshida, A., Shimohira, I., Matsuno, K., Mita, S., & Ueda, H. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00651-2 · Cited by 15
Sigma receptors: recent advances and new clinical potentials
Bowen, W. D. (2000) · Pharmacochemistry library · doi:10.1016/s0165-7208(00)80020-3 · Cited by 15
Involvement of κ-opioid and σ receptors in short-term memory in mice
Hiramatsu, M., Hoshino, T., Kameyama, T., & Nabeshima, T. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02388-9 · Cited by 14
Bermack, J. E., & Debonnel, G. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106063996 · Cited by 14
Binding of σ receptor ligands and their effects on muscarine-induced Ca2+ changes in SH-SY5Y cells
Hong, W. C., & Werling, L. L. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01606-5 · Cited by 13
The antidepressant mechanism of Hypericum perforatum
Mennini, T. (2004) · Life Sciences · doi:10.1016/s0024-3205(04)00350-9 · Cited by 10
van Berckel, B. N. M. (2003) · Current Neuropharmacology · doi:10.2174/1570159033477026 · Cited by 9
Cited by
Mu Opioids and Their Receptors: Evolution of a Concept
Pasternak, G. W., & Pan, Y.-X. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.007138 · Cited by 578
Lenze, E. J., Mattar, C., Zorumski, C. F., Stevens, A., Schweiger, J., Nicol, G. E., Miller, J. P., Yang, L., Yingling, M., Avidan, M. S., et al. (2020) · JAMA · doi:10.1001/jama.2020.22760 · Cited by 495
Crystal structure of the human σ1 receptor
Schmidt, H. R., Zheng, S., Gurpinar, E., Koehl, A., Manglik, A., & Kruse, A. C. (2016) · Nature · doi:10.1038/nature17391 · Cited by 482
Polypharmacology – Foe or Friend?
Peters, J.-U. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400856t · Cited by 465
Rosen, D. A., Seki, S. M., Fernández-Castañeda, A., Beiter, R. M., Eccles, J. D., Woodfolk, J. A., & Gaultier, A. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau5266 · Cited by 288
Metadata
- Authors
- Cobos, E., Entrena, J., Nieto, F., Cendan, C., & Pozo, E.
- Venue
- Current Neuropharmacology
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2008-12-01
- Volume
- 6
- Issue
- 4
- Pages
- 344-366
- ISSN
- 1570-159X (ISSN-L)
- OpenAlex
- W2000941955
- Cited by
- 376
- References
- 196
- FWCI
- 6.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.